Old Web
English
Sign In
Acemap
>
authorDetail
>
Melvin R. White
Melvin R. White
Bristol-Myers Squibb
Endocrinology
Internal medicine
Muraglitazar
Biology
Biochemistry
4
Papers
107
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Intermittent dosing of the transforming growth factor beta receptor 1 inhibitor, BMS‐986260, mitigates class‐based cardiovascular toxicity in dogs but not rats
2020
Journal of Applied Toxicology
Gregory D. Rak
Melvin R. White
Karen Augustine-Rauch
Courtni Newsome
Michael J. Graziano
Gene E. Schulze
Show All
Source
Cite
Save
Citations (7)
Toxicity of Pexacerfont, a Corticotropin-Releasing Factor Type 1 Receptor Antagonist, in Rats and Dogs:
2019
International Journal of Toxicology
Melvin R. White
Michael Graziano
Thomas P. Sanderson
Show All
Source
Cite
Save
Citations (2)
Urine acidification has no effect on peroxisome proliferator-activated receptor (PPAR) signaling or epidermal growth factor (EGF) expression in rat urinary bladder urothelium.
2007
Toxicology and Applied Pharmacology
William E. Achanzar
Carolyn F. Moyer
Laura T. Marthaler
Russell Gullo
Shen-Jue Chen
Michele H. French
Linda Watson
James W. Rhodes
John Kozlosky
Melvin R. White
William R. Foster
James J. Burgun
Bruce D. Car
Gregory N. Cosma
Mark A. Dominick
Show All
Source
Cite
Save
Citations (12)
Urothelial Carcinogenesis in the Urinary Bladder of Male Rats Treated with Muraglitazar, a PPARα/γ Agonist: Evidence for Urolithiasis as the Inciting Event in the Mode of Action
2006
Toxicologic Pathology
Mark A. Dominick
Melvin R. White
Thomas P. Sanderson
Terry R. Van Vleet
Samuel M. Cohen
Lora E. Arnold
Marty Cano
Sarah H. Tannehill-Gregg
Jeffrey D. Moehlenkamp
Crystal R. Waites
Beth E. Schilling
Show All
Source
Cite
Save
Citations (86)
1